drugset
drugset / Trial / NCT01014104

Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome

NCT01014104 ↗

Phase 1/2 Completed 218 enrolled Royan Institute
RandomizedParallel-groupOpen-labelPrevention

Summary

This study is a prospective randomized clinical controlled trial to assess the efficacy of the Methylprednisolone for preventing ovarian hyper stimulation syndrome in in vitro fertilization (IVF) cycles.

Timeline

Start
2009-10
Primary completion
2010-08
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 16 mg Intravenous

Indications

ovarian hyperstimulation syndrome